News Releases
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jul 17, 2014Record HBDC Placements and Strength in North America Reagents Drive 27% Clinical Growth
-
Jun 19, 2014Carbapenem Resistance Consortium Includes AstraZeneca, Cepheid, Cubist, and GSK
-
Jun 16, 2014On-demand molecular test detects and differentiates the genes encoding the most prevalent carbapenemases: KPC, NDM, VIM, OXA-48 and IMP-1
-
May 22, 2014
-
Apr 29, 2014
-
Apr 17, 2014Strong Commercial and HBDC Drive Clinical Growth of 26%
-
Apr 10, 2014Accurate Norovirus Detection in as Short as One Hour
-
Apr 2, 2014Xpert HPV is the Only Test Capable of Reporting High-risk Human Papillomavirus DNA in Captured Cervical Cells
-
Mar 21, 2014Partnering to Increase Awareness About Tuberculosis, a Curable and Preventable Disease that Infects One-third of the World's Population
-
Mar 20, 2014Custom Bike Designed by Paul Teutul Jr. to Lead the March Down Broadway to Highlight the Fight Against Tuberculosis in Honor of World TB Day
-
Jan 30, 2014Record Commercial GeneXpert® System Placements and Strong Commercial Reagent Growth Highlight Building Momentum as Xpert® Test Menu Expands
-
Dec 18, 2013
-
Oct 17, 2013First $100 Million Revenue Quarter Driven by Record Commercial Clinical and HBDC Sales
